Menu Back toSession 10: Track A: Considering the Implications of International Differences in Regulation on Life Science Advertising and Promotions Regulatory Affairs
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Advertising and Promotion Regulatory Affairs Conference
Session 10: Track A: Considering the Implications of International Differences in Regulation on Life Science Advertising and Promotions Regulatory Affairs
Ratinder Dhami, MS, RAC
- Director, Regulatory Affairs
- Network Partners, United States
Industry creates global marketing strategies for healthcare products but navigating the different adverting and promotional requirements across regions can be difficult. This session will discuss the similarities and differences in the regulations that govern Direct to Consumer Advertising (DTCA) for medical devices in Canada, EU, and US. Presenters will describe key principles for advertising strategies in a global market and provide an overview of the process and procedures that affect international reviews.
Learning Objective :
Upon completion of this session, the participant should be able to:
- Identify similarities and differences for advertising and promotion requirements in Canada, US, and EU
- Determine when and how to use a core claims document
- Evaluate how the review process for promotional material varies between regions, therapeutic area, and classification
Optimizing Product Launch in Canada
John Wong, MPharm
- TPIreg/Innomar Strategies, Canada
Navigating International Waters for Social Media and DTCA
Madhavi Bellamkonda, MSc
- Director Regulatory Affairs, Advertising & Promotion
- Abbott, United States